Literature DB >> 24797385

Do we need PET?

Heinrich R Schelbert1.   

Abstract

Mesh：

Year:  2014        PMID： 24797385     DOI： 10.1007/s12350-014-9906-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  11 in total

1.  Cost analysis of PET and comprehensive lifestyle modification for the reversal of atherosclerosis.

Authors:  Rigoberto I Delgado; J Michael Swint; David R Lairson; Nils P Johnson; K Lance Gould; Stefano Sdringola
Journal:  J Nucl Med       Date:  2013-12-12       Impact factor: 10.057

2.  Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Gilda Di Carli; Ron Blankstein; Sharmila Dorbala; Arkadiusz Sitek; Michael J Pencina; Marcelo F Di Carli
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

3.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.

Authors:  Maria C Ziadi; Robert A Dekemp; Kathryn A Williams; Ann Guo; Benjamin J W Chow; Jennifer M Renaud; Terrence D Ruddy; Niroshi Sarveswaran; Rebecca E Tee; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

Review 4.  PET and SPECT in cardiovascular molecular imaging.

Authors:  Lawrence W Dobrucki; Albert J Sinusas
Journal:  Nat Rev Cardiol       Date:  2009-11-24       Impact factor: 32.419

5.  Prognostic value of PET myocardial perfusion imaging in obese patients.

Authors:  Benjamin J W Chow; Sharmila Dorbala; Marcelo F Di Carli; Michael E Merhige; Brent A Williams; Emir Veledar; James K Min; Michael J Pencina; Yeung Yam; Li Chen; Sai Priya Anand; Terrence D Ruddy; Daniel S Berman; Leslee J Shaw; Rob S Beanlands
Journal:  JACC Cardiovasc Imaging       Date:  2014-02-19

6.  Economic outcomes in the Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in Coronary Artery Disease registry: the SPARC Study.

Authors:  Mark A Hlatky; David Shilane; Rory Hachamovitch; Marcelo F Dicarli
Journal:  J Am Coll Cardiol       Date:  2014-03-18       Impact factor: 24.094

Review 7.  Advanced imaging of cardiac sarcoidosis.

Authors:  Imke Schatka; Frank M Bengel
Journal:  J Nucl Med       Date:  2013-11-14       Impact factor: 10.057

8.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve.

Authors:  Bernhard A Herzog; Lars Husmann; Ines Valenta; Oliver Gaemperli; Patrick T Siegrist; Fabian M Tay; Nina Burkhard; Christophe A Wyss; Philipp A Kaufmann
Journal:  J Am Coll Cardiol       Date:  2009-07-07       Impact factor: 24.094

9.  Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.

Authors:  Sharmila Dorbala; Marcelo F Di Carli; Rob S Beanlands; Michael E Merhige; Brent A Williams; Emir Veledar; Benjamin J W Chow; James K Min; Michael J Pencina; Daniel S Berman; Leslee J Shaw
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

10.  Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.

Authors:  Michael T Osborne; Edward A Hulten; Avinainder Singh; Alfonso H Waller; Marcio S Bittencourt; Garrick C Stewart; Jon Hainer; Venkatesh L Murthy; Hicham Skali; Sharmila Dorbala; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2013-12-03       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.